# A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

> **NCT06909799** · NA · RECRUITING · sponsor: **The Aurum Institute NPC** · enrollment: 242 (estimated)

## Conditions studied

- Tuberculosis (TB)

## Interventions

- **DRUG:** N-Acetyl Cysteine (NAC)
- **DRUG:** Standard TB treatment

## Key facts

- **NCT ID:** NCT06909799
- **Lead sponsor:** The Aurum Institute NPC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-28
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 242 (ESTIMATED)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06909799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06909799, "A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06909799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*